Intellipharmaceutics International Inc. IPCIF
0.15 +0.15
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Nov 30, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Nov 30, 2022 | FY 2021 Nov 30, 2021 | FY 2020 Nov 30, 2020 | FY 2019 Nov 30, 2019 | FY 2018 Nov 30, 2018 |
|---|---|---|---|---|---|
| 65.73K | 0 | 1.40M | 3.48M | 1.71M | |
| 65.73K | 0 | 1.40M | 3.45M | 1.59M | |
| -2.85M | -4.17M | -2.18M | -7.83M | -13.33M | |
| -2.89M | -5.15M | -3.39M | -8.08M | -13.75M | |
| -0.09 | -0.17 | -0.14 | -0.37 | -2.89 |
Balance sheet
| Fiscal year | FY 2022 Nov 30, 2022 | FY 2021 Nov 30, 2021 | FY 2020 Nov 30, 2020 | FY 2019 Nov 30, 2019 | FY 2018 Nov 30, 2018 |
|---|---|---|---|---|---|
| 83.72K | 771.95K | 202.05K | 64.62K | 6.64M | |
| 1.43M | 2.10M | 3.39M | 3.80M | 11.47M | |
| 12.01M | 10.25M | 9.70M | 7.49M | 7.37M | |
| 2.33M | 1.92M | 2.11M | 1.90M | 1.79M | |
| -10.58M | -8.16M | -6.31M | -3.69M | 4.10M |
Cash flow
| Fiscal year | FY 2022 Nov 30, 2022 | FY 2021 Nov 30, 2021 | FY 2020 Nov 30, 2020 | FY 2019 Nov 30, 2019 | FY 2018 Nov 30, 2018 |
|---|---|---|---|---|---|
| -1.39M | -2.46M | 112.11K | -6.66M | -12.51M | |
| 500.00K | 0 | 25.32K | -14.47K | -101.18K | |
| 200.00K | 3.03M | 0 | 100.90K | 17.35M | |
| 500.00K | 0 | 25.32K | -14.47K | -101.18K | |
| -688.22K | 569.90K | 137.42K | -6.58M | 4.74M |